Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,750.00
Bid: 10,650.00
Ask: 10,850.00
Change: 300.00 (2.87%)
Spread: 200.00 (1.878%)
Open: 10,725.00
High: 10,750.00
Low: 10,725.00
Prev. Close: 10,450.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Dia-Stron Limited

1 Apr 2016 07:00

RNS Number : 8058T
Judges Scientific PLC
01 April 2016
 

Press Release

1 April 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Acquisition of Dia-Stron Limited

 

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces that it has today acquired 100% of the issued share capital of Dia-Stron Limited ("Dia-Stron"), an instrument maker based in Andover, Hampshire. Dia-Stron designs and manufactures systems to test the mechanical properties of fibres (the "Acquisition"). The Board expects the Acquisition to be immediately earnings enhancing.

 

The purchase price of Dia-Stron amounted to £2.75 million in cash. An additional payment will be made to reflect any excess working capital over and above the ongoing requirements of the business. The Board expects such payment to be covered by the cash inherited at the completion date.

 

Information on Dia-Stron

Dia-Stron specialises in the design and manufacture of systems to test the mechanical properties of fibres, primarily in relation to tensile strength. The company is a market leader in testing natural hair fibres and approximately 75 per cent of revenues are derived from the hair care industry, including large multi-national groups. The balance of sales is comprised of industrial fibres, skin-testing instruments and contract testing for third parties. The automation built into the company's systems provides significant efficiency savings for customers.

 

All of Dia-Stron's products are designed by the company, manufactured in Hampshire and sold worldwide to end users directly, through agents or through the company's US office ("Dia-Stron US"). The company's contract testing activities have, historically, been conducted in the US by Mar-Tech Contract Services Inc., a related company ("Mar-Tech); these activities, along with certain assets of Dia-Stron US, were transferred to Dia-Stron in the UK prior to completion of the Acquisition.

 

Dia-Stron was established in 1987 by Dr Nigel Winsey (Managing Director), Mrs Lynn Winsey (Finance Director and Company Secretary), Dr Steve Bucknell (Technical Director) and Mrs Tessa Bucknell (shareholder). Dr Winsey will continue as Managing Director until the end of the year to facilitate a smooth transition and Dr Bucknell will remain with the company as Technical Director.

 

Dia-Stron's stand-alone accounts for the financial year to 31 March 2015 show revenues of £1.48 million and pre-tax profits of £0.59 million. Net tangible assets amounted to £0.81 million, including cash of £0.55 million. These accounts do not include the assets or profits of Dia-Stron US and Mar-Tech which were acquired by Dia-Stron prior to completion of the Acquisition and are not material in the context of the transaction.

 

Dia-Stron's operating profits for the 12-month period ended 30 August 2015, adjusted (i) to include the profit contribution of Dia-Stron US and an estimate of the recurring annual profit of Mar-Tech and (ii) to eliminate non-recurring items and to reflect Dia-Stron's ongoing cost base within Judges, would have totalled £0.66 million on sales of £1.67 million. Dia-Stron owns a long leasehold property valued at £0.14 million.

 

Financing of the Acquisition

The Acquisition and associated transaction costs are being financed from Judges' existing cash resources.

 

The Board believes that Dia-Stron is an attractive and highly innovative business which enjoys a strong position in its worldwide niche market and an excellent reputation for quality and service.

 

Alex Hambro, Chairman of Judges, commented:

 

"Dia-Stron is an excellent company which has developed a first class reputation in its niche market and can be expected to have a positive and immediate impact on the Group's financial performance. We are delighted to welcome Nigel, Steve and their colleagues to Judges' management team."

 

- Ends -

 

 

 

 

For further information please contact:

 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, FD

 

Tel: 020 3829 6970

 

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Edward Mansfield

 

Tel: 020 7408 4090

 

Abchurch (Financial Public Relations)

Philip Dennis

Quincy Allan

Nessyah Hart

Tel: 020 7398 7700

 

 

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group holds 5 Queens' awards for innovation and export.

 

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQAKDDNBBKBDNN
Date   Source Headline
16th Apr 20247:00 amRNSDirector/PDMR Shareholding
9th Apr 20245:29 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:41 amRNSTotal Voting Rights - Correction
2nd Apr 20249:03 amRNSTotal Voting Rights
25th Mar 20246:01 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSFinal Results
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
4th Mar 202411:04 amRNSTotal Voting Rights
22nd Feb 20245:20 pmRNSHolding(s) in Company
6th Feb 20243:03 pmRNSDirector/PDMR Shareholding
5th Feb 20249:32 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSAcquisition of Luciol Instruments SA
24th Jan 20245:52 pmRNSGrant of Options
18th Jan 20247:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 20242:21 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:49 amRNSTotal Voting Rights
21st Dec 20234:16 pmRNSDirector/PDMR Shareholding
21st Dec 20239:13 amRNSBlock listing Interim Review
7th Dec 202311:18 amRNSDirector/PDMR Shareholding
1st Dec 202311:20 amRNSTotal Voting Rights
22nd Nov 202310:41 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSBoard Changes
15th Nov 202312:54 pmRNSDirector/PDMR Shareholding
9th Nov 202312:36 pmRNSDirector/PDMR Shareholding
9th Oct 202311:36 amRNSDirector/PDMR Shareholding
3rd Oct 202311:13 amRNSTotal Voting Rights
26th Sep 202310:37 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSNotice of Investor Presentation
2nd Aug 20233:02 pmRNSTotal Voting Rights
26th Jul 202311:20 amRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
10th Jul 20233:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20233:44 pmRNSTotal Voting Rights
22nd Jun 20233:09 pmRNSBlock listing Interim Review
14th Jun 20238:44 amRNSDirector/PDMR Shareholding
6th Jun 20238:45 amRNSPayment of Earn-out and Issue of Equity
5th Jun 20234:17 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSBlocklisting Application and Total Voting Rights
22nd May 20231:45 pmRNSResult of AGM
12th May 20232:01 pmRNSPurchase of Ordinary Shares
9th May 202312:37 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSNotice of AGM
2nd May 20231:00 pmRNSTotal Voting Rights
2nd May 20237:00 amRNSAcquisition of Bossa Nova Vision LLC
25th Apr 20235:55 pmRNSDirector/PDMR Shareholding
6th Apr 20232:50 pmRNSDirector/PDMR Shareholding
4th Apr 202312:21 pmRNSTotal Voting Rights
3rd Apr 20237:01 amRNSAcquisition of Henniker Scientific Limited
3rd Apr 20237:00 amRNSAppointment of Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.